A more than 30-year commitment to understanding human metabolic regulation has helped Christopher Newgard discover new insights and potential new therapies for metabolic diseases such as diabetes, obesity, and cardiovascular disease.

Howard Rockman’s discoveries have led to new treatments for heart disease. He is a national expert and sought-after speaker on issues of cardiac atrophy and heart failure.

Anna Mae Diehl, the director of the Duke Liver Center, is heralded around the world for her work on liver regeneration and non-alcoholic fatty liver disease.

As founding director of the Duke Global Health Institute, Michael Merson is internationally respected as a seminal leader in global health and education.